TABLE 4.
Proportion of resistance (median) for selected infection site, by antibiotics and pathogen, in Egypt, Ethiopia, Madagascar, Malawi, Mali, Mozambique, Nigeria, South Africa, Sudan, Tunisia, Uganda and Zambia between 2016 and 2018.
| Infection site | Antibiotic | Pathogen | Proportion of resistance (median) |
||
|---|---|---|---|---|---|
| 2016 | 2017 | 2018 | |||
| Bloodstream infection | Carbapenems | Escherichia coli | 0.4 | 7.7 | 5.0 |
| Klebsiella pneumoniae | 23.4 | 15.2 | 20.4 | ||
| Penicillinase beta lactams | Staphylococcus aureus | 24.7 | 22.7 | 21.1 | |
| Third-generation cephalosporins | E. coli | 61.9 | 51.5 | 50.3 | |
| K. pneumoniae | 81.8 | 84.4 | 84.5 | ||
| Urinary tract infection | Carbapenems | E. coli | 0.7 | 0.7 | 7.3 |
| K. pneumoniae | 17.1 | 9.7 | 9.4 | ||
| Ciprofloxacin | E. coli | 57.4 | 48.2 | 59.7 | |
| K. pneumoniae | 58.3 | 36.3 | 49.1 | ||